DEVELOPMENT AND PRODUCTION OF SOLID DOSAGE FORMS

发展治疗学药物资源分会 国家癌症研究所(NCI)癌症治疗部计划，是 寻求承包商为制造提供工作人员和设施 以及生产用于人类研究的固体口服剂型。 每年的生产任务数量将接近六个项目。 由10,000到300,000片/胶囊的批号组成。这个 准备好的产品将用于NCI赞助的整个临床试验 整个世界。NCI将使用从该承包商获得的数据 人员对产品的完整性进行评估，并支持IND NCI向美国食品和药物管理局提交的申请 (FDA)。

The Pharmaceutical Resources Branch of the Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute (NCI), is seeking a contractor to provide a staff and facility for the manufacture and production of solid oral dosage forms for investigational use in man. The number of production assignments will approximate six projects annually consisting of batch sizes from 10,000 to 300,000 tablets/capsules. The products prepared will be usedfor NCI-sponsored clinical trials throughout the world. Data obtained from this contractor will be used by NCI personnel to evaluate the integrity of the product, and to support IND applications submitted by the NCI to the U. S. Food and Drug Administration (FDA).